VAM
SCLN

Visium Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Visium Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-17,915
Closed -$176K – 1326
2015
Q2 		$176K Buy
17,915
+315
+2% +$2.87K ﹤0.01% 999
2015
Q1 		$156K Buy
+17,600
New +$140K ﹤0.01% 949

Other funds holding SCLN

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SI
Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

Visium Asset Management's SCLN Position: Q3 2015 in Review

Visium Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2015, closing a stake of 17,915 shares — an estimated $176K sold.

Visium Asset Management first reported a position in SCLN in Q1 2015 and held it in 2 quarters. The position peaked at $176K in Q2 2015. 134 funds tracked by Wall St. Rank hold SCLN as of Q3 2015.

  • Visium Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2015 after selling out during the quarter.
  • Visium Asset Management sold 17,915 Sciclone Pharmaceuticals Inc shares in Q3 2015, an estimated $176K.
  • Visium Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q1 2015 and held it in 2 quarters.
  • Visium Asset Management's Sciclone Pharmaceuticals Inc position peaked at $176K in Q2 2015.
  • 134 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2015.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.